{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Azolidines as beta-3 adrenergic receptor agonists", "item": "https://www.patentleaderboard.com/patent/6569873"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Azolidines as beta-3 adrenergic receptor agonists

Azolidines as beta-3 adrenergic receptor agonists

US Patent 6569873 · Granted May 27, 2003

Estimated economic value: $625,583,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and use thereof2020
ABHD6 and dual ABHD6/MGL inhibitors and their uses2020
N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use ther2020
N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use ther2018
Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase2011
Amino-pyridines as inhibitors of β-secretase2010
Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibi2010
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-s2010
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-s2010
Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase2010
Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase2010
Imidazole amines as inhibitors of β-secretase2010